GlassScriptPhysician profile
Hong Lei
NPI 1487780284
$21,479.36
in general payments reported to CMS, 2019-2025
15 companies · $286 in 2025
The $286 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30.68 · 2020: $80.65 · 2021: $1,639 · 2022: $9,795 · 2023: $9,248 · 2024: $400 · 2025: $286.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,635 · Food and Beverage: $1,058 · Travel and Lodging: $130 · Education: $111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,635.00 |
| Food and Beverage | $1,057.97 |
| Travel and Lodging | $129.56 |
| Education | $111.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $20,045.12 | 2021-2023 | Austedo Xr, Austedo |
| Abbott Laboratories | $627.40 | 2021-2025 | Infinity, Eterna |
| Abbvie INC. | $343.61 | 2020-2025 | |
| Novartis Pharmaceuticals Corporation | $133.90 | 2020-2025 | |
| Neurocrine Biosciences, INC. | $74.16 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $60.00 | 2023 | Gammagard Liquid |
| Noctrix Health, INC. | $57.05 | 2025 | Nidra |
| Allergan, INC. | $28.20 | 2019-2020 | |
| Acadia Pharmaceuticals INC | $21.47 | 2020 | |
| Mdd US Operations, LLC | $19.44 | 2021 | |
| Boston Scientific Corporation | $19.15 | 2022 | |
| Horizon Therapeutics Plc | $18.25 | 2022 | |
| Biogen, INC. | $15.63 | 2019 | |
| Amneal Pharmaceuticals LLC | $15.15 | 2020 | |
| Travere Therapeutics, INC. | $0.83 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hong Lei listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.